Profound Medical Corp (TO:PRN) — Stock Price
Profound Medical Corp (TO:PRN) is currently trading at CA$10.20 CAD, down 0.97% today. Over the past 52 weeks, shares have ranged between CA$5.35 and CA$12.11. This page tracks Profound Medical Corp's live share price on the TO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PRN market cap.
Profound Medical Corp (PRN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Profound Medical Corp's daily closing share price and trading volume on the TO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Profound Medical Corp Income Statement — Revenue, Profit & Earnings by Year
Profound Medical Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CA$22.49 Million | CA$10.68 Million | CA$7.20 Million | CA$6.68 Million | CA$6.87 Million |
| Cost of Revenue | CA$6.57 Million | CA$3.64 Million | CA$2.82 Million | CA$3.66 Million | CA$3.92 Million |
| Gross Profit | CA$15.92 Million | CA$7.04 Million | CA$4.38 Million | CA$3.02 Million | CA$2.95 Million |
| Research & Development | CA$28.78 Million | CA$16.96 Million | CA$14.38 Million | CA$14.69 Million | CA$15.28 Million |
| SG&A | CA$32.05 Million | CA$23.13 Million | CA$9.17 Million | CA$9.46 Million | CA$10.31 Million |
| Total Operating Expenses | CA$73.56 Million | CA$40.10 Million | CA$33.00 Million | CA$32.62 Million | CA$33.24 Million |
| Operating Income | CA$-57.64 Million | CA$-33.06 Million | CA$-28.62 Million | CA$-29.60 Million | CA$-30.29 Million |
| EBITDA | CA$-56.86 Million | CA$-32.13 Million | CA$-27.00 Million | CA$-34.63 Million | CA$-28.65 Million |
| EBIT | CA$-57.64 Million | CA$-33.06 Million | CA$-27.93 Million | CA$-36.72 Million | CA$-31.00 Million |
| Interest Expense | — | — | CA$770.00K | CA$174.00K | CA$303.00K |
| Income Before Tax | CA$-59.13 Million | CA$-27.82 Million | CA$-28.70 Million | CA$-28.38 Million | CA$-30.59 Million |
| Income Tax Expense | CA$352.12K | CA$-2.00K | CA$-128.00K | CA$287.00K | CA$105.00K |
| Net Income | CA$-59.48 Million | CA$-27.82 Million | CA$-28.57 Million | CA$-28.67 Million | CA$-30.70 Million |
Profound Medical Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Profound Medical Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CA$193.10 Million | CA$70.23 Million | CA$43.91 Million | CA$64.42 Million | CA$86.78 Million |
| Total Current Assets | CA$104.30 Million | CA$69.06 Million | CA$41.90 Million | CA$62.02 Million | CA$77.12 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CA$7.20 Million | CA$7.04 Million | CA$7.29 Million | CA$6.34 Million | CA$1.41 Million |
| Inventory | CA$11.29 Million | CA$5.80 Million | CA$6.99 Million | CA$7.94 Million | CA$7.41 Million |
| Property, Plant & Equipment | CA$882.00K | CA$821.00K | CA$1.57 Million | CA$1.72 Million | CA$1.90 Million |
| Goodwill | — | — | — | CA$0.00 | CA$2.69 Million |
| Total Liabilities | CA$102.04 Million | CA$9.81 Million | CA$12.73 Million | CA$12.42 Million | CA$6.16 Million |
| Total Current Liabilities | CA$8.33 Million | CA$6.57 Million | CA$6.37 Million | CA$4.18 Million | CA$4.16 Million |
| Long-term Debt | CA$4.50 Million | CA$2.92 Million | CA$5.00 Million | CA$6.65 Million | — |
| Net Debt | CA$-75.41 Million | CA$-49.79 Million | CA$-18.35 Million | CA$-38.29 Million | CA$-65.78 Million |
| Total Stockholder Equity | CA$91.06 Million | CA$60.42 Million | CA$31.18 Million | CA$52.00 Million | CA$80.62 Million |
| Retained Earnings | CA$-394.42 Million | CA$-245.17 Million | CA$-217.93 Million | CA$-189.36 Million | CA$-160.69 Million |
Profound Medical Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Profound Medical Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-53.39 Million | CA$-23.45 Million | CA$-22.61 Million | CA$-25.80 Million | CA$-22.36 Million |
| Capital Expenditures | CA$245.93K | CA$0.00 | CA$0.00 | CA$0.00 | CA$593.00K |
| Free Cash Flow | CA$-53.63 Million | CA$-23.45 Million | CA$-22.30 Million | CA$-25.80 Million | CA$-22.95 Million |
| Investing Cash Flow | CA$-338.14K | — | — | CA$0.00 | CA$-593.00K |
| Financing Cash Flow | CA$57.48 Million | CA$54.70 Million | CA$1.46 Million | CA$7.03 Million | CA$5.95 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$5.49 Million | CA$2.58 Million | CA$3.42 Million | CA$4.24 Million | CA$7.21 Million |
| Depreciation | CA$782.48K | CA$936.00K | CA$1.15 Million | CA$1.60 Million | CA$1.88 Million |
| Change in Cash | CA$2.89 Million | CA$28.70 Million | CA$-20.30 Million | CA$-20.64 Million | CA$-16.76 Million |
Profound Medical Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Profound Medical Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 07, 2026 | -0.26 | -0.35 | +25.97% |
| Mar 05, 2026 | -0.37 | -0.38 | +2.63% |
| Nov 13, 2025 | -0.36 | -0.52 | +30.77% |
| Aug 14, 2025 | -0.72 | -0.55 | -30.91% |
| May 08, 2025 | -0.50 | -0.40 | -25.00% |
| Mar 05, 2025 | -0.29 | -0.45 | +36.99% |
| Nov 07, 2024 | -0.53 | -0.42 | -26.19% |
| Aug 08, 2024 | -0.38 | -0.39 | +2.56% |